{"id":8831,"date":"2025-05-12T12:56:55","date_gmt":"2025-05-12T12:56:55","guid":{"rendered":"https:\/\/firearmman.com\/?p=8831"},"modified":"2025-05-12T12:56:58","modified_gmt":"2025-05-12T12:56:58","slug":"pharmaceutical-industry-criticizes-the-drug-pricing-plan-trump-will-sign","status":"publish","type":"post","link":"https:\/\/firearmman.com\/?p=8831","title":{"rendered":"Pharmaceutical industry criticizes the drug pricing plan Trump will sign"},"content":{"rendered":"
\n

WASHINGTON — <\/span>President Donald Trump’s<\/a> plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. <\/p>\n

Trump has promised that his plan \u2014 which is likely to tie the price of medications covered by Medicare and administered in a doctor\u2019s office to the lowest price paid by other countries \u2014 will significantly lower drug costs. <\/p>\n

\u201cI will be instituting a MOST FAVORED NATION\u2019S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World,\u201d the Republican president posted on social media on Sunday, pledging to sign the order on Monday morning at the White House. <\/p>\n

But the nation’s leading pharmaceutical lobby on Sunday pushed back, calling it a \u201cbad deal\u201d for American patients. Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs. <\/p>\n

\u201cImporting foreign prices will cut billions of dollars from Medicare with no guarantee that it helps patients or improves their access to medicines,\u201d Stephen J. Ubl, the president and CEO of PhRMA, said in a statement. \u201cIt jeopardizes the hundreds of billions our member companies are planning to invest in America, making us more reliant on China for innovative medicines.\u201d <\/p>\n

Trump’s so-called \u201cmost favored nation\u201d approach to Medicare drug pricing has been controversial since he first tried to implement it during his first term. He signed a similar executive order<\/a> in the final weeks of his presidency, but a court order<\/a> later blocked the rule from going into effect under President Joe Biden’s administration. <\/p>\n

The pharmaceutical industry has argued that Trump\u2019s 2020 attempt would give foreign governments the \u201cupper hand\u201d in deciding the value of medicines in the U.S.<\/p>\n

It’s likely that Trump’s executive order Monday will only impact drugs covered by Medicare Part B, the insurance for doctor\u2019s office visits. Medicare beneficiaries are responsible for picking up some of the costs to get those medications during doctor\u2019s visits, and for traditional Medicare enrollees there is no annual out-of-pocket cap on what they pay.<\/p>\n

A report<\/a> by the first Trump administration found that the U.S. spends twice as much as some other countries in covering those drugs. Medicare Part B drug spending topped $33 billion in 2021. <\/p>\n

Trump has played up the announcement, saying it will save taxpayers big money. <\/p>\n

\u201cOur Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,\u201d Trump added. <\/p>\n

But many Americans won’t see the savings. <\/p>\n

Trump’s proposal would likely only impact certain drugs covered by Medicare and given in an office \u2014 think infusions that treat cancer, and other injectables. But it could potentially bring billions of dollars in savings to the government \u2014 not necessarily the \u201cTRILLIONS OF DOLLARS\u201d Trump boasted about in his post. <\/p>\n

Medicare provides health insurance for roughly 70 million older Americans. Complaints about U.S. drug prices being notoriously high, even when compared with other large and wealthy countries, have long drawn the ire of both major political parties, but a lasting fix has never cleared Congress. <\/p>\n

More common prescription drugs<\/a> filled at a pharmacy would probably not be covered by the new order. <\/p>\n

Trump\u2019s post formally previewing the action came after he teased a \u201cvery big announcement\u201d last week. He gave no details, except to note that it wasn\u2019t related to trade or the tariffs<\/a> he has announced for much of the world. <\/p>\n

\u201cWe\u2019re going to have a very, very big announcement to make \u2014 like as big as it gets,\u201d Trump said last week.<\/p>\n

He came into his first term accusing pharmaceutical companies of \u201cgetting away with murder\u201d and complaining that other countries whose governments set drug prices were taking advantage of Americans.<\/p>\n

On Sunday, Trump took aim at the industry again, writing that the \u201cPharmaceutical\/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the \u2018suckers\u2019 of America, ALONE.\u201d <\/p>\n

Referring to drug companies\u2019 powerful lobbying efforts, he said that campaign contributions \u201ccan do wonders, but not with me, and not with the Republican Party.\u201d <\/p>\n

\u201cWe are going to do the right thing,\u201d he wrote. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON — President Donald Trump’s plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. Trump has promised that his plan \u2014 which is likely to tie […]<\/p>\n","protected":false},"author":1,"featured_media":8832,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-8831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-news"],"_links":{"self":[{"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/posts\/8831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/firearmman.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8831"}],"version-history":[{"count":1,"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/posts\/8831\/revisions"}],"predecessor-version":[{"id":8833,"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/posts\/8831\/revisions\/8833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/firearmman.com\/index.php?rest_route=\/wp\/v2\/media\/8832"}],"wp:attachment":[{"href":"https:\/\/firearmman.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/firearmman.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/firearmman.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}